Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$87,436,460
+$45,223,059 QoQ
Shares Held
3,936,806
+69.1% QoQ
Ownership
2.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 245 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. DYN ranks #50 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in DYN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,436,460 | 3,936,806 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $42,213,401 | 2,328,373 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $45,453,312 | 2,323,789 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,685,800 | 1,398,087 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,695,232 | 2,383,953 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,041,540 | 1,820,415 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $56,601,768 | 2,402,452 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $94,695,644 | 2,636,293 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $83,498,574 | 2,366,069 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,140,091 | 1,132,092 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $179,575 | 13,502 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,571,466 | 175,387 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $123,108 | 10,943 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,355,890 | 291,310 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $452,913 | 39,078 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $491,591 | 38,708 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $251,167 | 36,560 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $351,455 | 36,458 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $425,162 | 35,758 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $590,453 | 36,358 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $10,183,992 | 484,952 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,922,799 | 491,471 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||